PLx Pharma Inc reports results for the quarter ended in December - Earnings Summary

PLx Pharma Winddown

11/03/2022 14:31

* PLx Pharma Inc  PLXP.OQ  reported quarterly adjusted
earnings of
10 cents​​ per share for the quarter ended in December. The mean
expectation of four analysts for the quarter was for a loss
of 71 cents per share.
    * Revenue was $1.59 million​;  analysts expected $2.05
million. 
    * PLx Pharma Inc's reported EPS for the quarter was 10
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * PLx Pharma Inc shares had fallen by 45.3% this quarter.
    * The company reported quarterly net income of $3.56
million.
    * Wall Street's median 12-month price target for PLx Pharma
Inc is
$21.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 11 at 02:31 p.m.  ​All
figures in US dollars unless otherwise stated